Bright Minds Biosciences Inc. (DRUG)

Bright Minds Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	57.9	5.72	6.75	11.63	19.76	0.8
Cash & Short-Term Investments	57.9	5.72	6.75	11.63	19.76	0.8
Cash Growth	756.25%	-15.23%	-41.97%	-41.15%	2370.22%	900.02%
Other Receivables	0.07	0.05	0.04	0.16	0.11	-
Receivables	0.07	0.05	0.04	0.16	0.11	-
Prepaid Expenses	0.26	0.22	0.03	0.16	0.17	0.08
Total Current Assets	58.22	5.99	6.81	11.95	20.04	0.88
Property, Plant & Equipment	0.18	0.12	0.07	0.14	-	-
Other Intangible Assets	-	-	-	-	0	0
Total Assets	58.4	6.1	6.88	12.09	20.04	0.88
Accounts Payable	0.37	0.41	0.18	1.25	0.6	0.14
Accrued Expenses	0.02	0.04	0.03	0.16	0.04	0.01
Current Portion of Leases	0.07	0.08	0.07	0.07	-	-
Total Current Liabilities	0.46	0.53	0.28	1.47	0.64	0.15
Long-Term Leases	0.11	0.04	-	0.07	-	-
Total Liabilities	0.57	0.57	0.28	1.54	0.64	0.15
Common Stock	89.02	35.42	33.91	32.24	27.08	0.98
Retained Earnings	-34.3	-34.35	-31.55	-24.17	-9.21	-0.56
Comprehensive Income & Other	3.11	4.46	4.23	2.48	1.53	0.31
Shareholders' Equity	57.83	5.54	6.6	10.54	19.4	0.73
Total Liabilities & Equity	58.4	6.1	6.88	12.09	20.04	0.88
Total Debt	0.18	0.12	0.07	0.14	-	-
Net Cash (Debt)	57.71	5.6	6.67	11.49	19.76	0.8
Net Cash Growth	760.49%	-16.08%	-41.90%	-41.86%	2370.22%	900.02%
Net Cash Per Share	11.80	1.30	1.79	4.65	11.01	1.11
Filing Date Shares Outstanding	7.04	6.99	4.46	3.74	2.37	1.27
Total Common Shares Outstanding	6.99	4.52	3.77	3.52	2.37	0.95
Working Capital	57.76	5.46	6.53	10.48	19.4	0.73
Book Value Per Share	8.27	1.22	1.75	3.00	8.20	0.77
Tangible Book Value	57.83	5.54	6.6	10.54	19.4	0.73
Tangible Book Value Per Share	8.27	1.22	1.75	3.00	8.20	0.77

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q